- Report
- November 2026
- 375 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 484 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 383 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 141 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 565 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 387 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 676 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 392 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 166 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 244 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 212 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- November 2026
- 217 Pages
Global
From €5466EUR$5,850USD£4,566GBP
- Report
- August 2026
- 120 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2026
- 110 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2026
- 100 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 100 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 120 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 112 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- August 2026
- 182 Pages
Global
From €4438EUR$4,750USD£3,708GBP
- Report
- July 2026
- 145 Pages
Global
From €4438EUR$4,750USD£3,708GBP

Single Use Bioreactors (SUBs) are bioreactors that are designed for a single use and then disposed of. They are used in biotechnology for the production of biopharmaceuticals, such as vaccines, monoclonal antibodies, and recombinant proteins. SUBs are typically made of plastic and are pre-sterilized, eliminating the need for cleaning and sterilization between batches. This makes them ideal for rapid scale-up and production of biopharmaceuticals. SUBs also offer advantages such as reduced risk of contamination, improved process control, and reduced capital costs.
The SUB market is growing rapidly due to the increasing demand for biopharmaceuticals and the need for rapid scale-up and production. SUBs are becoming increasingly popular in the biotechnology industry due to their cost-effectiveness and convenience.
Some companies in the SUB market include Sartorius, Thermo Fisher Scientific, Merck KGaA, GE Healthcare, and Pall Corporation. Show Less Read more